Pituitary tumor cosecreting thyrotropin and prolactin causing hyperthyroidism--a case report.
We report a case of a pituitary tumor cosecreting thyrotropin and prolactin with clinical manifestation of thyrotoxicosis, which is a very rare clinical disorder. Octreotide therapy is effective in suppressing the secretion of thyrotropin, prolactin, and thyroid hormones, and by this, renders relief of symptoms and complications of thyrotoxicosis.
Department of Medicine, Taichung Veterans General Hospital, Taiwan.
Y M
YM
Song
W H
WH
Sheu
D000236:Adenoma / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D013971:Thyrotoxicosis / Q000209:etiology; D013972:Thyrotropin / Q000378:metabolism*
D011388:Prolactin; D013972:Thyrotropin; D015282:Octreotide